Neurology® Podcast

Dr. Gordon Smith talks with Dr. Charlotte Sumner about spinal muscular atrophy, highlighting the historic milestone reached with three medications receiving FDA approval for the treatment of SMA.

Dr. Jason Crowell talks with Drs. Ariane Lewis and David Magnus about the need to update the Uniform Declaration of Death Act (UDDA), aligning the legal criteria with the medical standards used to determine death by neurological criteria. Read the full article in Neurology.

Dr. Jeff Burns talks with Dr. Lon Schneider about the development of ARIA in the Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of Alzheimer disease.

Dr. Alex Menze talks with Dr. Raquel Gardner about the development of a clinically-relevant definition of poor cognitive outcome one year after mild traumatic brain injury (mTBI) and whether outcomes can be predicted by baseline clinical variables. Read the full article in Neurology.

This episode features Dr. Stacey Clardy in conversation with the 2022 Ted Burns Humanism in Neurology Award Winner, Dr. Barbara Giesser.

Dr. Gregg Day talks with Dr. Niklas Mattsson-Carlgren about the correlation of cerebrospinal fluid biomarkers with autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Read the full article in Neurology.

Dr. Shuvro Roy talks with Dr. Alberto Ascherio about the association of Epstein-Barr virus infection and increased risk of multiple sclerosis, highlighting stronger evidence for this viral connection.

Dr. Jeff Ratliff talks with Dr. Christos Ganos about the use of brain lesion network mapping to interrogate whether tic disorder-inducing lesions are associated with a common network in the average human brain.

Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sclerosis. Read the full article at 46brooklyn.com.

The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Michelle Mauermann in conversation with Dr. Bart Jacobs over the course of a decade, highlighting the progress he and his team have made in treating and predicting outcomes in GBS over time.